Biosimilar Versus Urinary Gonadotropins

NCT02503605 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Infertility

Interventions

DRUG: Biosimilar recombinant FSH
DRUG: Urinary FSH

Sponsor

IVI Madrid

Collaborators

[object Object]